|
|
|
|
BCX-1777
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called purine nucleoside phosphorylase (PNP) enzyme inhibitors. (National Cancer Institute)
BioCryst Pharmaceuticals Successfully Completes Phase I Trial With ... Mar 15, 2005
BioCryst's first lead product candidate, forodesine hydrochloride (BCX-1777), another transition-state analog inhibitor of PNP, is currently in a Phase IIa ... PR Newswire (press release)
BioCryst to Raise Approximately $23.9 Million Through Sale of ... Feb 17, 2005
BioCryst’s lead product candidate, forodesine hydrochloride (formerly known as BCX-1777), an inhibitor of purine nucleoside phosphorylase (PNP), is currently ... mysan.de (Pressemitteilung),
Archives: The following articles may no longer be available on the web. If you want to inquire on a particular article, please contact the source publication (listed in parentheses).
<**results**>
BioCryst Added to Russell 3000(R) Index Jun 29, 2004
BioCryst's lead product candidate, forodesine hydrochloride (BCX-1777), an inhibitor of purine nucleoside phosphorylase (PNP), is currently in a Phase IIa ... Yahoo News (press release) -
BBCI to Manage BioCryst Pharmaceuticals' Phase II Clinical Trial ... Jun 10, 2004
KANSAS CITY, Mo., June 10 /PRNewswire/ -- BBCI, an international contract research organization, announced that it is providing clinical trial management ... Yahoo News (press release) -
Resources from the National Cancer Institute on BCX-1777:
Cancer.gov Phase I Study of BCX-1777 in Patients With Refractory T-Cell or Non-T-Cell
Malignancies. Date First Published: 2003-11-20. BASIC STUDY INFORMATION. ...
Cancer.gov Phase I/II Study of BCX-1777 in Patients With Refractory Cutaneous T-Cell Lymphoma. ... Phase
II: Patients receive treatment as in phase I at the MTD of BCX-1777. ...
Cancer.gov Phase I Study of BCX-1777 in Patients With Refractory Hematologic Malignancies.
Date Last Modified: 2004-05-06. Date First Published: 2003-07-26. ...
Cancer.gov - Dictionary ...cells live longer. Also called augmerosen. BCX-1777 A substance that
is being studied in the treatment of cancer. It belongs to ...
|
|
|
